首页> 外文期刊>The journal of asthma >Genetic variation of myeloperoxidase gene contributes to atopic asthma susceptibility: a preliminary association study in Russian population.
【24h】

Genetic variation of myeloperoxidase gene contributes to atopic asthma susceptibility: a preliminary association study in Russian population.

机译:髓过氧化物酶基因的遗传变异有助于特应性哮喘易感性:在俄罗斯人群中的初步关联研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Recently, we have shown that both antioxidant and oxidant genes are proper candidates for asthma susceptibility genes. OBJECTIVES: In the present study we investigated whether a common polymorphism -463G > A in the promoter of myeloperoxidase (MPO) gene, an enzyme producing hypohalogenic oxidants, is associated with the risk of bronchial asthma. METHODS: We studied 429 unrelated Russian subjects including 215 asthmatic patients and 214 sex- and age-matched healthy controls from Central Russia. The genotyping of the polymorphism -463G > A in the MPO gene was performed by the polymerase chain reaction and the restriction fragment length polymorphism assays. RESULTS: It was found that a carriage of a -463A allele is associated with decreased risk of asthma (OR 0.64 95%CI 0.44-0.91, p = 0.013). Furthermore, variant genotypes (-463GA + AA) of the MPO gene were associated with decreased risk of asthma (OR adjusted by age, gender, and immunoglobulin E (IgE) level was 0.63 95%CI 0.42-0.95), but at a borderline statistical significance (Bonferroni corrected p = 0.017). Further analysis revealed that both a -463A allele and the -463GA/AA genotypes are significantly associated with decreased risk of atopic asthma (p = 0.01). No association of the -463G > A polymorphism of the MPO gene with non-atopic asthma has been revealed. We also found that the allele -463A (OR = 0.47 95%CI 0.27-0.81, p = 0.01) and the -463GA + AA genotypes (OR 0.43 95%CI 0.24-0.78, p = 0.005) are significantly associated with decreased risk of late-onset atopic asthma (the disease onset after 30 years). No association of both allele and genotypes of the polymorphism -463G > A of the MPO gene with early-onset of atopic and non-atopic asthma (the disease before 30 years) was seen. CONCLUSIONS: The results of this study provide novel insights into pathogenesis of bronchial asthma. We put forward a suggestion about a possible mechanism by which the -463G > A polymorphism of the MPO gene is involved into pathogenesis of asthma.
机译:背景:最近,我们已经证明抗氧化剂和氧化剂基因都是哮喘易感基因的合适候选者。目的:在本研究中,我们调查了髓过氧化物酶(MPO)基因(一种产生低卤素氧化剂的酶)的启动子中常见的多态性-463G> A是否与支气管哮喘风险相关。方法:我们研究了429名无关的俄罗斯受试者,包括215名来自俄罗斯中部的哮喘患者和214名性别和年龄匹配的健康对照。 MPO基因多态性-463G> A的基因分型通过聚合酶链反应和限制性片段长度多态性分析进行。结果:发现携带-463A等位基因与哮喘风险降低相关(OR 0.64 95%CI 0.44-0.91,p = 0.013)。此外,MPO基因的不同基因型(-463GA + AA)与哮喘风险降低相关(OR年龄,性别和免疫球蛋白E(IgE)水平调整为0.63 95%CI 0.42-0.95),但处于临界点统计学显着性(Bonferroni校正的p = 0.017)。进一步的分析表明,-463A等位基因和-463GA / AA基因型均与特应性哮喘风险降低显着相关(p = 0.01)。没有发现-463G> MPO基因的多态性与非特应性哮喘的相关性。我们还发现等位基因-463A(OR = 0.47 95%CI 0.27-0.81,p = 0.01)和-463GA + AA基因型(OR 0.43 95%CI 0.24-0.78,p = 0.005)与降低的风险显着相关迟发性特应性哮喘(30年后发病)。没有观察到MPO基因多态性-463G> A的等位基因和基因型与特应性和非特应性哮喘(30岁之前的疾病)的早发相关。结论:本研究结果为支气管哮喘的发病机理提供了新的见解。我们对MPO基因的-463G> A多态性参与哮喘发病的可能机制提出了建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号